Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
Clinical trial NCT01983735 · UNKNOWN
Trial details
- NCT number
- NCT01983735
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.